Back to results
US 11,890,378 B2Granted
Compositions and methods for treating disorders ameliorated by muscarinic receptor activation
AssigneeKaruna Therapeutics, Inc.
InventorsAimesther Betancourt, Bruce Rehlaender, Roch Thibert
Life of this patent
Estimating the term…
Abstract
Provided herein is an oral pharmaceutical composition, comprising a plurality of xanomeline beads having a core comprising xanomeline or a salt thereof; and a plurality of trospium beads having a core comprising a salt of trospium.
Claims14
A oral pharmaceutical composition, comprising:
- a plurality of xanomeline beads comprising xanomeline or a salt thereof;
- and
- a plurality of trospium beads comprising trospium chloride;
- the composition having a dosage strength chosen from:
- 50 mg xanomeline free base and 20 mg trospium chloride,
- 100 mg xanomeline free base and 20 mg trospium chloride, and
- 125 mg xanomeline free base and 30 mg trospium chloride.
4 more elements
Dependencies are inferred from the claim text.